venBio Global Strategic GP II, Ltd.
10% owner at Checkmate Pharmaceuticals, Inc.
- Sold, on record
- $8.5M
- Dollars the filings state
- Form 4 sales
- 2
- Latest May 4, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Checkmate Pharmaceuticals, Inc.10% owner
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Checkmate Pharmaceuticals, Inc.Plan not statedApr 21, 2022 2022
Sold 547,734 shares at $10.41 ($5.7M)
venBio Global Strategic GP II, Ltd., 10% owner
Sold 14.9% of holdings ($38.2M position)3.1M shares leftFirst sale on recordFiling
- 2 Form 4 sale Checkmate Pharmaceuticals, Inc.Plan not statedMay 4, 2022 +13 days
Sold 270,675 shares at $10.38 ($2.8M)
venBio Global Strategic GP II, Ltd., 10% owner
Sold 9.6% of holdings ($29.1M position)2.5M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2022 | May 4, 2022 | Checkmate Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 270,675 | $2.8M | 9.6% | Plan not stated | SEC |
| Apr 21, 2022 | Apr 21, 2022 | Checkmate Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 547,734 | $5.7M | 14.9% | Plan not stated | SEC |